Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Gurupur, Gautham Shenoy"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Puralae Channabasavaiah Jagadish, Prajakta Harish Patil, Fajeelath Fatima, Sumit Birangal, Gurupur Gautham Shenoy, Mahadev Rao, Junaid Farooqui, Himanshu Rastogi, Tarun Sharma, Jakir Pinjari
Publikováno v:
Current Drug Metabolism. 23:137-149
Background and objective: Concurrent usage of proton pump inhibitors and their effect on survival and medication termination has been found in individuals receiving protein kinase inhibitor chemotherapy. To investigate the drug-drug interaction mecha
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b024f93ca9931eaadaad0c0a70fe2d2
https://doi.org/10.2174/1389200223666220218090948
https://doi.org/10.2174/1389200223666220218090948
Autor:
Subham Das, Angel Treasa Alex, Alex Joseph, Anu Kunnath Ramachandran, Jayesh Mudgal, Gurupur Gautham Shenoy
Publikováno v:
Current Neuropharmacology
Alzheimer’s disease (AD) is a complex neurodegenerative disease that leads to insidious deterioration of brain functions and is considered the sixth leading cause of death in the world. Alzheimer’s patients suffer from memory loss, cognitive defi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ac4dc685cfc6d3db2d1023adb05bcb5d
https://doi.org/10.2174/1570159x18666200807130637
https://doi.org/10.2174/1570159x18666200807130637
Publikováno v:
CNSneurological disorders drug targets.
Abstract: COVID-19, which primarily affects the pulmonary system, turned out to be a global pandemic, whereas the effects on other systems are still unknown. SARS-CoV-2, binds to angiotensin-converting enzyme 2 (ACE2) receptors in the lungs, causing
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc2f9aa5780bd7a389cedf58c70c8347
https://pubmed.ncbi.nlm.nih.gov/36573058
https://pubmed.ncbi.nlm.nih.gov/36573058
Autor:
Prajakta Harish Patil, Mrunal Desai, Rajat Radhakrishna Rao, Srinivas Mutalik, Gurupur Gautham Shenoy, Mahadev Rao, Puralae Channabasavaiah Jagadish
Publikováno v:
Journal of Applied Pharmaceutical Science.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ff21c7a0330bcc93a8228b7278dc08eb
https://doi.org/10.7324/japs.2022.120505
https://doi.org/10.7324/japs.2022.120505
Autor:
Varadaraj Bhat Giliyar, Pritesh Bhat, Amol B. Khade, Mradul Tiwari, Vandana Kalwaje Eshwara, Sidhartha S Kar, Cinu T Alummoottil, Gurupur Gautham Shenoy, Ashutosh Prasad Tiwari
Publikováno v:
Medicinal Chemistry. 16:256-270
Background: The well-known antibacterial agent Triclosan (TCL) that targets bacterial enoylacyl protein reductase has been described to inhibit human fatty acid synthase (FASN) via the enoylacyl reductase domain. A Literature survey indicates that TC
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cc0ad5cec3ac4dbe7de85d4d247294fd
https://doi.org/10.2174/1573406415666190306152907
https://doi.org/10.2174/1573406415666190306152907